Third dose of BNT162b2 COVID-19 vaccine effective at decreasing risk of hospitalization [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
1. This observational cohort study demonstrated that among long-term care residents in Israel, the BNT162b2 (Pfizer-BioNTech) booster dose (third overall ...
1. Two doses of the Pfizer-BioNTech BNT162b2 vaccine were linked to high immediate protection again severe acute respiratory syndrome coronary ...
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of symptomatic Covid-19 infection and hospitalization compared to ...
1. Two doses of BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccine provided good protection against the Omicron (B.1.1.529) variant but rapidly ...
1. Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable protection against hospitalization and death. 2. However, ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.